Meredith Riebschleger

507 total citations
16 papers, 273 citations indexed

About

Meredith Riebschleger is a scholar working on Speech and Hearing, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Meredith Riebschleger has authored 16 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Speech and Hearing, 6 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Meredith Riebschleger's work include Adolescent and Pediatric Healthcare (8 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Innovations in Medical Education (3 papers). Meredith Riebschleger is often cited by papers focused on Adolescent and Pediatric Healthcare (8 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Innovations in Medical Education (3 papers). Meredith Riebschleger collaborates with scholars based in United States, Canada and Australia. Meredith Riebschleger's co-authors include Hilary M. Haftel, Jeremy Adler, Elizabeth A. Kessler, Carol Carraccio, Daniel J. Schumacher, Patricia J. Hicks, Robert Englander, Nico Wulffraat, Jordi Antón and Sheila Oliveira and has published in prestigious journals such as SHILAP Revista de lepidopterología, Academic Medicine and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Meredith Riebschleger

15 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meredith Riebschleger United States 8 119 83 63 50 38 16 273
Maureen Haugen United States 10 94 0.8× 55 0.7× 47 0.7× 13 0.3× 28 0.7× 14 309
Shilpa Venkatachalam United States 12 90 0.8× 45 0.5× 20 0.3× 75 1.5× 15 0.4× 38 367
Daniel Clemente Spain 10 74 0.6× 53 0.6× 89 1.4× 53 1.1× 68 1.8× 39 374
Tova Ronis United States 8 80 0.7× 42 0.5× 80 1.3× 56 1.1× 15 0.4× 18 263
Christine A. Johnson United States 9 105 0.9× 50 0.6× 33 0.5× 17 0.3× 22 0.6× 14 293
Rita Secola United States 11 91 0.8× 98 1.2× 10 0.2× 22 0.4× 28 0.7× 22 336
Kerry Morrone United States 11 161 1.4× 40 0.5× 17 0.3× 15 0.3× 30 0.8× 33 372
Naomi Winick United States 14 145 1.2× 340 4.1× 54 0.9× 16 0.3× 24 0.6× 15 624
Ifeyinwa Osunkwo United States 9 336 2.8× 47 0.6× 18 0.3× 23 0.5× 21 0.6× 29 482
Nick Croft United Kingdom 8 104 0.9× 23 0.3× 116 1.8× 33 0.7× 18 0.5× 17 412

Countries citing papers authored by Meredith Riebschleger

Since Specialization
Citations

This map shows the geographic impact of Meredith Riebschleger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith Riebschleger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith Riebschleger more than expected).

Fields of papers citing papers by Meredith Riebschleger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith Riebschleger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith Riebschleger. The network helps show where Meredith Riebschleger may publish in the future.

Co-authorship network of co-authors of Meredith Riebschleger

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith Riebschleger. A scholar is included among the top collaborators of Meredith Riebschleger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith Riebschleger. Meredith Riebschleger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Turnier, Jessica L., Meredith Riebschleger, Nadine Saad, et al.. (2025). Tape strip expression profiling of juvenile dermatomyositis skin reveals mitochondrial dysfunction contributing to disease endotype. JCI Insight. 10(8). 2 indexed citations
2.
Boehnke, Kevin F., et al.. (2021). Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis. Pediatric Rheumatology. 19(1). 171–171. 5 indexed citations
3.
Shenoi, Susan, Kristen Hayward, Megan L. Curran, et al.. (2020). Telemedicine in pediatric rheumatology: this is the time for the community to embrace a new way of clinical practice. Pediatric Rheumatology. 18(1). 85–85. 20 indexed citations
4.
Srinivasalu, Hemalatha & Meredith Riebschleger. (2019). Medical education in pediatric rheumatology—unique challenges and opportunities. Clinical Rheumatology. 39(3). 643–650. 8 indexed citations
5.
Sturza, Julie, et al.. (2018). Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis. Pediatric Rheumatology. 16(1). 2–2. 8 indexed citations
6.
Sahinoz, Melis, Graham F. Brady, Rasimcan Meral, et al.. (2018). Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis. SHILAP Revista de lepidopterología. 4(1). 6–6. 11 indexed citations
7.
Moorthy, Lakshmi N., Eyal Muscal, Meredith Riebschleger, et al.. (2015). Efficacy of an Interinstitutional Mentoring Program Within Pediatric Rheumatology. Arthritis Care & Research. 68(5). 645–651. 7 indexed citations
8.
Riebschleger, Meredith, et al.. (2014). Noncompletion in Pediatric Rheumatology Fellowships. Journal of Graduate Medical Education. 6(1). 158–161. 3 indexed citations
9.
Riebschleger, Meredith, Heather A. Van Mater, Lisa Cohn, & Sarah J. Clark. (2014). Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type. Pediatric Rheumatology. 12(1). 2 indexed citations
10.
Riebschleger, Meredith, et al.. (2014). A163: Alternative Mechanisms of Care Delivery in Pediatric Rheumatology: To What Extent Do They Expand the Reach of Pediatric Rheumatologists?. Arthritis & Rheumatology. 66(S3). 4 indexed citations
11.
Muscal, Eyal, Lakshmi N. Moorthy, Meredith Riebschleger, et al.. (2014). A177: Program Evaluation of the ACR/CARRA Inter‐Institutional Mentoring Program (AMIGO) in Pediatric Rheumatology. Arthritis & Rheumatology. 66(S3).
12.
Riebschleger, Meredith & Hilary M. Haftel. (2013). Remediation in the Context of the Competencies: A Survey of Pediatrics Residency Program Directors. Journal of Graduate Medical Education. 5(1). 60–63. 25 indexed citations
13.
Riebschleger, Meredith, et al.. (2013). Meta-analysis: rapid infliximab infusions are safe. Alimentary Pharmacology & Therapeutics. 38(4). 365–376. 31 indexed citations
14.
Kimura, Yukiko, Jennifer E. Weiss, Tzielan Lee, et al.. (2012). Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis. Arthritis Care & Research. 65(5). 745–752. 102 indexed citations
15.
Schumacher, Daniel J., et al.. (2012). Perspective. Academic Medicine. 87(7). 883–888. 44 indexed citations
16.
Riebschleger, Meredith & Hilary M. Haftel. (2011). Remediation in Pediatric Residency Programs: A Survey of Pediatric Program Directors. Academic Pediatrics. 11(4). e7–e7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026